Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS

The fixed-dose combination (FDC) elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/c/FTC/TDF) is a once-daily, single-tablet regimen containing an integrase strand transfer inhibitor and a pharmacoenhancer (cobicistat) associated with two nucleos(t)ide reverse transcriptase inhibitors. It is appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Prinapori, Roberta, Di Biagio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556264/
https://www.ncbi.nlm.nih.gov/pubmed/26345643
http://dx.doi.org/10.2147/PPA.S88490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556264/
https://www.ncbi.nlm.nih.gov/pubmed/26345643
http://dx.doi.org/10.2147/PPA.S88490

Ejemplares similares